References
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
- RazaASoodGKHepatocellular carcinoma review: current treatment, and evidence-based medicineWorld J Gastroenterol201420154115412724764650
- ZhangJZhouZGHuangZXProspective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinomaChin J Cancer20163512526956022
- BruixJShermanMPractice Guidelines Committee, American Association for the Study of Liver DiseasesManagement of hepatocellular carcinomaHepatology20054251208123616250051
- European Association for the Study of the Liver, European Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
- PalmerDHSorafenib in advanced hepatocellular carcinomaN Engl J Med20083592324982499
- ParkJWChenMColomboMGlobal patterns of hepatocellular carcinoma management from diagnosis to death: the bridge studyLiver Int20153592155216625752327
- LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology200337242944212540794
- BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
- LlovetJMBurroughsABruixJHepatocellular carcinomaLancet200336293991907191714667750
- BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
- FerreriAJMIllerhausGZuccaECavalliFInternational Extranodal Lymphoma Study GroupFlows and flaws in primary central nervous system lymphomaNat Rev Clin Oncol20107812
- TempletonAJKnoxJJLinXChange in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacyEur Urol201670235836426924770
- TempletonAJMcNamaraMGŠerugaBPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisJ Natl Cancer Inst20141066dju12424875653
- DengMMaXLiangXZhuCWangMAre pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?Oncotarget2017823372003720728380461
- RossiSBassoMStrippoliAAre markers of systemic inflammation good prognostic indicators in colorectal cancer?Clin Colorectal Cancer201716426427428412137
- SongWTianCWangKZhangRJZouSBPreoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: a systematic review and meta-analysisPLoS One2017126e017876228575033
- ZhaoYSiGZhuFPrognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysisOncotarget2017814228542286228206965
- DongLBaiKCaoYHuangQLvLJiangYPrognostic value of pre-operative platelet to lymphocyte ratio in patients with resected primary hepatocellular carcinomaClin Lab201662112191219628164677
- HeCBLinXJInflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101PLoS One2017123e017476928355305
- YangTZhuJZhaoLLymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resectionJ Surg Oncol2017115671872828127774
- BruixJShermanMLlovetJMClinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the LiverJ Hepatol200135342143011592607
- LeeYHHsuCYHuangYHVascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impactJ Clin Gastroenterol201448873474124100755
- WangDSLuoHYQiuMZComparison of the prognostic values of various inflammation based factors in patients with pancreatic cancerMed Oncol20122953092310022476808
- ProctorMJMorrisonDSTalwarDAn inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome studyBr J Cancer2011104472673421266974
- LuoJGuoRPLaiECTransarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative studyAnn Surg Oncol201118241342020839057
- GalunDBogdanovicADjokic KovacJBulajicPLoncarZZuvelaMPreoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing countryCancer Manag Res20181097798829765248
- FlussRFaraggiDReiserBEstimation of the Youden index and its associated cutoff pointBiom J200547445847216161804
- PedrazzaniCMantovaniGFernandesEAssessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancerSci Rep201771149428473700
- KitanoYYamashitaYIYamamuraKEffects of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios on survival in patients with extrahepatic cholangiocarcinomaAnticancer Res20173763229323728551669
- CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
- MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
- GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
- Bard-ChapeauEANguyenATRustAGTransposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse modelNat Genet2014461243224316982
- JiangDKSunJCaoGGenetic variants in Stat4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinomaNat Genet2013451727523242368
- EndigJBuitrago-MolinaLEMarhenkeSDual role of the adaptive immune system in liver injury and hepatocellular carcinoma developmentCancer Cell201630230832327478039
- MohsAKuttkatNReißingJFunctional role of CCL5/RAN-TES for HCC progression during chronic liver diseaseJ Hepatol201766474375328011329
- WangYZhengCLiangBHepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemo-embolization in a standardized rabbit modelJ Vasc Interv Radiol201122111606161221959058
- ChaoYWuCYKuoCYCytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolizationHepatol Int20137388389226201926
- McNallyMEMartinezAKhabiriHInflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolizationAnn Surg Oncol201320392392822965570
- SiebenMHerzerKZeidlerMKilling of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia proteinWorld J Gastroenterol200814243819382818609705
- LiYYuDCChenYA hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicinCancer Res200161176428643611522637
- de VisserKEEichtenACoussensLMParadoxical roles of the immune system during cancer developmentNat Rev Cancer200661243716397525
- JaiswalMLarussoNFBurgartLJGoresGJInflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanismCancer Res200060118419010646872
- IshigamiSNatsugoeSTokudaKPrognostic value of intratumoral natural killer cells in gastric carcinomaCancer200088357758310649250
- DannenbergAJSubbaramaiahKTargeting cyclooxygenase-2 in human neoplasia: rationale and promiseCancer Cell20034643143614706335
- SchoppmannSFBirnerPStöcklJTumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisAm J Pathol2002161394795612213723
- LiuCHChangSHNarkoKOverexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic miceJ Biol Chem200127621185631856911278747
- WiesnerTBuglSMayerFHartmannJTKoppHGDifferential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancerClin Exp Metastasis201027314114920182908
- DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
- StotzMPichlerMAbsengerGThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerBr J Cancer2014110243544024357796
- ZouWImmunosuppressive networks in the tumour environment and their therapeutic relevanceNat Rev Cancer20055426327415776005
- ZhangNGuJYinLIncorporation of alpha-fetoprotein (AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER databaseOncotarget2016749813898140127835609
- LiZXueTQChenXYPredictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACEAm J Cancer Res20166102375238527822426
- WuSJLinYXYeHXiongXZLiFYChengNSPrognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resectionInt J Surg201636Pt A14315127793641
- RekikSGuyotEBhaisMThe CRP level and state score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolizationDig Liver Dis20164891088109227375209
- LiuCJiaBSZouBWNeutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolizationMedicine20179645e851229137051
- TianXCLiuXLZengFRChenZWuDHPlatelet-to-lymphocyte ratio acts as an independent risk factor for patients with hepatitis B virus-related hepatocellular carcinoma who received transarterial chemoembolizationEur Rev Med Pharmacol Sci201620112302230927338055